January 2, 2024

Junshi Biosciences Announces Approval of the Supplemental New Drug Application for Toripalimab as Perioperative Treatment for Resectable NSCLC Patients

SHANGHAI, China, Jan. 02, 2024 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the supplemental new drug application (the “sNDA”) for toripalimab (trade name: TUOYI®, product code: JS001) in combination with chemotherapy […]

80 countries participate in Ministerial Roundtable

FMF strengthens the Kingdom’s leadership in enabling the Super Region to contribute to the metals industries of the future RIYADH, Saudi Arabia, Jan. 02, 2024 (GLOBE NEWSWIRE) — The Future Minerals Forum (FMF) announced today that its Ministerial Roundtable, due to be held on 9 January 2024, ahead of the third edition of the Forum, […]

Be sure before sharing in 2023.

Bangkok: Join us in reviewing 2023, the year when cyber threats grew and spread, the year when ‘fake news’ has not disappeared but has been circulating and emerging. The year that confirmed that Thai people still need to strengthen their immune system…